Your browser doesn't support javascript.
loading
Synthesis, evaluation and structural investigations of potent purple acid phosphatase inhibitors as drug leads for osteoporosis.
Feder, Daniel; Kan, Meng-Wei; Hussein, Waleed M; Guddat, Luke W; Schenk, Gerhard; McGeary, Ross P.
Afiliação
  • Feder D; The University of Queensland, School of Chemistry and Molecular Biosciences, Brisbane, QLD, 4072, Australia.
  • Kan MW; The University of Queensland, School of Chemistry and Molecular Biosciences, Brisbane, QLD, 4072, Australia.
  • Hussein WM; The University of Queensland, School of Chemistry and Molecular Biosciences, Brisbane, QLD, 4072, Australia; Helwan University, Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Ein Helwan, Helwan, Egypt.
  • Guddat LW; The University of Queensland, School of Chemistry and Molecular Biosciences, Brisbane, QLD, 4072, Australia.
  • Schenk G; The University of Queensland, School of Chemistry and Molecular Biosciences, Brisbane, QLD, 4072, Australia; The University of Queensland, Sustainable Minerals Institute, Brisbane, QLD, 4072, Australia. Electronic address: schenk@uq.edu.au.
  • McGeary RP; The University of Queensland, School of Chemistry and Molecular Biosciences, Brisbane, QLD, 4072, Australia. Electronic address: r.mcgeary@uq.edu.au.
Eur J Med Chem ; 182: 111611, 2019 Nov 15.
Article em En | MEDLINE | ID: mdl-31445230

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Osteoporose / Fosfatase Ácida / Inibidores Enzimáticos Limite: Animals / Humans Idioma: En Revista: Eur J Med Chem Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Osteoporose / Fosfatase Ácida / Inibidores Enzimáticos Limite: Animals / Humans Idioma: En Revista: Eur J Med Chem Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália